The concomitant use of conventional and herbal medicines can lead to clinically relevant herb-drug interactions. Clinical risk management offers a systematic approach to minimize the untoward consequences of these interactions by paying attention to: (i) risk identification and assessment; (ii) development and execution of risk reduction strategies; and (iii) evaluation of risk reduction strategies. This paper reviews which steps should be explored or taken in these domains to improve the clinical risk management of adverse herb-drug interactions. © 2006 The Author.
CITATION STYLE
De Smet, P. A. G. M. (2007, March). Clinical risk management of herb-drug interactions. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2006.02797.x
Mendeley helps you to discover research relevant for your work.